tm
Seeing Is Believing
tm
Seeing Is Believing
AVIR is currently covered by 2 analysts with an average potential upside of $3.62 (31.42%) backed by displayed 6 price targets and 12 ratings.
Analysts average stock forecasts to be materialized ratio is 53.33% with an average time for these price targets to be met of 56 days.
Highest price target for AVIR is 9, Lowest price target is 8, average price target is 8.5.
Most recent stock forecast was given by ERIC JOSEPH from JPMORGAN on 10-Aug-2023. First documented stock forecast 29-Jan-2021.
Currently, out of the existing stock ratings of AVIR - 1 which are a Hold (33.33%), 1 which are a Buy (33.33%), 1 which are a Sell (33.33%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
8
3 months 20 days ago
2/5 (40%)
$3.52 (37.47%)
60
Sell
7
$4.1 (141.38%)
14
1 years 3 months 15 days ago
4/6 (66.67%)
$3.72 (25.37%)
52
What is AVIR (Atea Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on AVIR (Atea Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on AVIR (Atea Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on AVIR (Atea Pharmaceuticals)?
Which analyst is the currently most bullish on AVIR (Atea Pharmaceuticals)?
Which analyst is the currently most reserved on AVIR (Atea Pharmaceuticals)?
